U.S. Rep. Frank Pallone Jr., D-N.J., introduced bipartisan legislation this week that would allow designated universities, including Rutgers, to partner with the Food and Drug Administration and industry to further develop and implement a faster, more efficient pharmaceutical manufacturing process. Learn more.
Recent Posts
- Rutgers Advances Non-Opioid Solutions for Chronic Pain.
- How Gender Bias Influences Math Education.
- Join NJ ACTS for Special Populations Seminar on 4/28 at 12pm
- Drug Metabolism Group Spring Symposium and Vendor Exhibition on May 5th
- Rutgers Health Begins Clinical Trial to Determine If B1 Can Slow Alzheimer’s Disease.
Categories
- Community (2,477)
- Covid (999)
- CTO Events (6)
- News (3,142)
- Pilots (21)